... Address: 1 University of Mainz, Mainz, Germany, 2 INSERM, Unité 580, Université Paris-Descartes, Paris, France, 3 University of Copenhagen, Copenhagen, Denmark, 4 Rigshospitalet, The National University Hospital, ...
... and Human Epidermal Growth Factor 2 (HER2), and had a high proliferative index as measured by a high proliferation ratio based on Ki-67 staining (Figure ...
... from human activated NK lymphocytes and inhibits cell-mediated ...within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic ...
... CTLA4-Ig meets all of the intervention criteria listed above. First, as a potent suppressive molecule used by Treg cells for immune suppression, 22 CTLA4-Ig can be substitutive for Treg cells. Second, CTLA4-Ig is highly ...
... 48 IV. ANTI-TUMOR IMMUNE RESPONSE The major feature of the immune system is its ability to recognize “self” from “foreign” and to destroy the latter, potentially dangerous for host homeostasis. In this context, the ...
... The specific cytotoxicity observed after co-cultivating PBMC with LB1319-MEL cells pretreated with the combination of hIFN- c and GGTI-298, suggests that these melanoma cells develop the ability to induce a specific ...
... 88 II- Aim of the study Background: Several lines of evidence indicate that an endogenous immune response against cancer develops in some patients. Tumor-specific CTL expand at relatively high frequency in cancer ...
... 88 II- Aim of the study Background: Several lines of evidence indicate that an endogenous immune response against cancer develops in some patients. Tumor-specific CTL expand at relatively high frequency in cancer ...
... plex to extrapolate to clinical settings. To overcome such a technical bottleneck, we designed an agent-based model, calibrated on experimental measurements, which accurately reproduces human CTL/tumor cell ...
... of human CTL efficacy against cancer ...of human CTL per capita killing ...of human CTL/tumor cell interaction is indeed crucial to define how efficient individual CTL are when facing cancer cells for a ...
... Les deux événements, SHM comme CSR, nécessitent la transcrip- tion des régions cibles sous le contrôle d’activateurs situés à l’extrémité 3’ du locus IgH, dans la région 3’ régulatric[r] ...
... The expression studies revealed that fluid extracted from the tumor interstitium upregulates specific CAMs on endothelial cells in vitro, which promotes lymphocyte bin[r] ...
... estradiol, human chorionic gonadotropin, luteinizing hormone, regulatoryT cells,T helper 17 cells, pregnancy INTRODUCTION Pregnancy constitutes an immunological paradox since it implies that a fetus ...
... ABSTRACT Cancer is one of the deadliest diseases worldwide. Chemotherapy remains one of the frequently applied treatment modalities in the clinics. However, as the currently applied agents are associated with severe ...
... 9. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 1994; 83:3101-3. 10. ...
... Figure 1: Structure of new low-cytotoxic nitrones targeting mitochondria New mito-PPNs were good EPR probes for biologically-relevant carbon- and oxygen-derived free radicals, efficiently inhibited superoxide in ...
... T lymphocyte destruction by HIV-1 REMERCIEMENTS Ce travail a été soutenu par le Centre National de la Recherche Scientifique (CNRS), l’Université Montpellier I (UMI), Sidaction et l’Agence Nationale de Recherche ...
... both cytotoxic lymphocytes and natural killer cells 11 , of cytokine-loaded vesicles in helper T cells 12,13 and of hydrolase-containing lysosomes in B cells 5,14 ...
... S1 Methods. Expression of stemness, pluripotency and differentiation markers in prolifer- ating and quiescent GSCs. The expression levels (mRNA) of 90 genes enclosing stemness, pluripotency and differentiation markers ...